| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/12/2012 | WO2012004726A1 Trans-epithelial osmotic collyrium for the treatment of keratoconus |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 01/12/2012 | WO2011116020A3 Ophthalmic formulations of cetirizine and methods of use |
| 01/12/2012 | WO2011112002A3 Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient |
| 01/12/2012 | WO2011068872A3 Carboxyvinyl polymer-containing nanoparticle suspension |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010288 Method for protecting a retinal neuronal cell |
| 01/12/2012 | US20120010283 Modulation of anxiety through blockade of anandamide hydrolysis |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010280 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 01/12/2012 | US20120010257 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010137 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120009223 COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009185 Method for treating age-related macular degeneration |
| 01/12/2012 | US20120009166 Isolated monocyte populations and related therapeutic applications |
| 01/12/2012 | US20120009146 Treatment and Diagnostic Methods for Fibrosis Related Disorders |
| 01/12/2012 | US20120009131 Method for preventing or treating amyloid beta peptide-associated diseases or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides |
| 01/12/2012 | US20120006323 Nasal devices |
| 01/12/2012 | DE102010026696A1 Use of a grease pencil for medical application of active ingredients on the edge of the eyelid, for e.g. treating allergic diseases of the eye, changes in intraocular pressure, preferably glaucoma, and inflammations of the eye |
| 01/12/2012 | CA2801361A1 Resveratrol-containing compositions and methods of use for cardiac related diseases |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2404895A1 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 01/11/2012 | EP2404606A1 Ophthalmic compositions comprising a prostaglandin and a viscosity agent |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2403937A2 Methods of inhibiting photoreceptor apoptosis |
| 01/11/2012 | EP2403853A1 Pyrrolopyrimidines used as kinase inhibitors |
| 01/11/2012 | EP2403503A2 Methods for treating ocular inflammatory diseases |
| 01/11/2012 | EP2403488A2 Controlled-release ophthalmic vehicles |
| 01/11/2012 | EP2403478A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | EP2403477A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | CN1642542B Angiogenesis inhibitors |
| 01/11/2012 | CN102317288A [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
| 01/11/2012 | CN102316868A Method for treating macular degeneration |
| 01/11/2012 | CN102316832A Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens |
| 01/11/2012 | CN102311485A Polypeptide with neovascularization suppression effect and application thereof |
| 01/11/2012 | CN102311396A Pyrazine derivative and preparation method as well as application thereof to pharmacy |
| 01/11/2012 | CN102311385A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/11/2012 | CN102309669A Chinese medicinal preparation for treating allergic conjunctivitis |
| 01/11/2012 | CN102309633A Magnetite health-care wine and preparation method thereof |
| 01/11/2012 | CN102309632A Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 01/11/2012 | CN102309630A Processing method for toxicity reduction and efficacy enhancement of rhizoma alismatis |
| 01/11/2012 | CN102309607A Chinese medicine decoction for treating diabetic retinopathy and preparation method thereof |
| 01/11/2012 | CN102309535A Traditional Chinese drug plaster for treating tinnitus |
| 01/11/2012 | CN102309529A Method for microwave extraction of aescine in Chinese buckeye seeds |
| 01/11/2012 | CN102309519A Production method of calamine powder |
| 01/11/2012 | CN102309516A Drug composition and application thereof |
| 01/11/2012 | CN102309429A Method for processing Chinese forest frog essence wrinkle removal beauty treatment and eyesight improving eye patch |
| 01/11/2012 | CN102078509B Traditional Chinese medicine preparation for treating ophthalmorrhagia and preparation method thereof |
| 01/11/2012 | CN101198354B Preventive or remedy for glaucoma |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8092825 Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
| 01/10/2012 | CA2496797C Therapeutic agent for glaucoma comprising rho kinase inhibitor and prostaglandin |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines |
| 01/05/2012 | WO2012003437A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/05/2012 | WO2012003141A1 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012000904A1 Pharmaceutical composition for use in the treatment of glaucoma |
| 01/05/2012 | WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof |
| 01/05/2012 | WO2012000055A1 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 01/05/2012 | WO2012000054A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 01/05/2012 | WO2011107877A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | US20120004320 Method for Treating Ocular Demodex |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004298 Ophthalmic devices containing chemokine antagonists |
| 01/05/2012 | US20120004274 Use of inhibitors of jun n-terminal kinases to treat glaucoma |
| 01/05/2012 | US20120004269 Alkynyl Phenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| 01/05/2012 | US20120004265 Ophthalmic Compositions and Methods of Using the Same |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004245 Compounds for the treatment of posterior segment disorders and diseases |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004226 Modulators of Muscarinic Receptors |
| 01/05/2012 | US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use |
| 01/05/2012 | US20120004217 Therapeutic agents useful for treating pain |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004158 Quaternised Ammonium Cyclodextrin Compounds |
| 01/05/2012 | US20120003323 Eye drops containing a deproteinized calf blood extract |
| 01/05/2012 | US20120003296 New methods of treating dry eye syndrome |
| 01/05/2012 | US20120003275 Compositions and Methods for the Treatment of Ophthalmic Disease |
| 01/05/2012 | US20120003230 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 01/05/2012 | US20120003224 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2 |
| 01/05/2012 | US20120003198 Lutein/Zeaxanthin for glare protection |
| 01/05/2012 | CA2803935A1 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease |
| 01/05/2012 | CA2803932A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 01/05/2012 | CA2799587A1 Compounds for the treatment of posterior segment disorders and diseases |